Last reviewed · How we verify
Acteylcysteine
At a glance
| Generic name | Acteylcysteine |
|---|---|
| Sponsor | Far Eastern Memorial Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- NAC to Prevent Cisplatin-induced Hearing Loss (PHASE1)
- The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |